Cancer stem cells with genetic instability: The best vehicle with the best engine for cancer

Gene Therapy

Volumn 15, Issue 2, 2008, Pages 136-142

  Lagasse, E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL INTERACTION; CELL REGENERATION; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; CLONAL VARIATION; COLON CANCER; GENETIC INSTABILITY; GENETIC STABILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOMATIC MUTATION;

CLONE CELLS; EVOLUTION, MOLECULAR; GENOMIC INSTABILITY; HUMANS; MUTATION; NEOPLASMS; NEOPLASTIC STEM CELLS; STEM CELLS;

BACTERIA (MICROORGANISMS);

EID: 37749016965     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303068     Document Type: Review

References (76)

1. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961; 14: 213-223.
2. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89: 2804-2808.
3. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science (Washington DC) 1988; 241: 58-62.
4. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 2003; 21: 759-806.
5. Merkle FT, Alvarez-Buylla A. Neural stem cells in mammalian development. Curr Opin Cell Biol 2006; 18: 704-709.
6. Anderson DJ. Stem cells and pattern formation in the nervous system: The possible versus the actual. Neuron 2001; 30: 19-35.
7. Hsieh J, Gage FH. Epigenetic control of neural stem cell fate. Curr Opin Genet Dev 2004; 14: 461-469.
8. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000; 97: 14720-14725.
9. Vogel G. Stem cells. Stemness' genes still elusive. Science 2003; 302: 371
10. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
11. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302-305.
12. Haupt Y, Alexander WS, Barri G, Klinken SP, Adams JM. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 1991; 65: 753-763.
13. Hosen N, Yamane T, Muijtjens M, Pharn K, Clarke MF, Weissman IL. Bud-1-green fluorescent protein-knock-in mice reveal the dynamic regulation of bmi-1 expression in normal and leukemic hematopoietic cells. Stem Cells 2007, 25: 1635-1644.
14. Pardal R, Molofsky AV, He S, Morrison SJ. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb Symp Quant Biol 2005; 70: 177-185.
15. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006, 441: 1068-1074.
16. Caussinus E, Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet 2005; 37: 1125-1129.
17. Nigg EA. Origins and consequences of centrosome aberrations in human cancers. Int J Cancer 2006; 119: 2717-2723.
18. Jefford CE, Irminger-Finger I. Mechanisms of chromosome instability in cancers. Crit Rev Oncol Hematol 2006; 59: 1-14.
19. Duensing S, Munger. K. Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta 2001; 1471: M81-M88.
20. Fuller MT, Spradling AC. Male and female Drosophila germline stem cells: Two versions of immortality. Science 2007; 316: 402-404.
21. Chen D, McKearin D. Gene circuitry controlling a stem cell niche. Curr Biol 2005; 15: 179-184.
22. Fukino K, Shen L, Patocs A, Mutter GL, Eng C. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 2007; 297: 2103-2111.
23. Ishiguro K, Yoshida T, Yagishita H, Numata Y, Okayasu T. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 2006; 55: 695-702.
24. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res 2000; 60: 2562-2566.
25. Fialkow PJ. Clonal origin of human tumors. Annu Rev Med 1979; 30:135-143.
26. Vogelstein B, Fearorr ER, Hamilton SR, Feinberg AP. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 1985; 227: 642-645.
27. Furth J, Kahn Jr JB. The transmission of leukemia of mice with a single cell. Am J Cancer 1936; 31: 276-282.
28. Nowell P, Hungerford D. A minute chromosome in human chromic granulocytic leukemia. Science 1960; 132: 1497.
29. Nowell PC. Tumor progression: A brief historical perspective. Semin Cancer Biol 2002; 12: 261-266.
30. Amagai M, Kawakubo Y, Tsuyuki A, Harada R. Lymphomatoid papulosis followed by Ki-1 positive anaplastic large cell lymphoma: Proliferation of a common T-cell clone. J Dermatol 1995; 22: 743-746.
31. Garcia SB, Novelli M, Wright NA. The clonal origin and clonal evolution of epithelial tumours. Int J Exp Pathol 2000; 81: 89-116.
32. German J. Genes which increase chromosomal instability in somatic cells and predispose to cancer. Prog Med Genet 1972; 8: 61-101.
33. Sieber OM, Heinimann K, Tomlinson IP. Genomic instability-the engine of tumorigenesis? Nat Rev Cancer 2003; 3: 701-708.
34. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10: 789-799.
35. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977; 197: 461-463.
36. Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS, Moon TE. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med 1978; 298: 1321-1327.
37. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977; 197: 893-895.
38. Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science 1982; 217: 998-1003.
39. Tonini GP, Romani M. Genetic and epigenetic alterations in neuroblastoma. Cancer Lett 2003; 197: 69-73.
40. Dick JE. Breast cancer stem cells revealed. Proc Natl Acad Sci USA 2003; 100: 3547-3549.
41. Cairns J. Mutation selection and the natural history of cancer. Nature 1975; 255: 197-200.
42. Buick RN, Pollak MN. Perspectives on clonogenic tumor cells, stem cells, and oncogenes. Cancer Res 1984; 44: 4909-4918.
43. Sell S, Pierce GB. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 1994; 70: 6-22.
44. Conheim J. Lectures on General Pathology. A Handbook for Practicians and Students. The New Sydenham Society: London, 1889.
45. Hennings H, Yuspa SH. Two-stage tumor promotion in mouse skin: An alternative interpretation. J Natl Cancer Inst 1985; 74: 735-740.
46. Morris RJ. A perspective on keratinocybe stem cells as targets for skin carcinogenesis. Differentiation 2004, 72: 381-386.
47. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737.
48. Galli R, Binds E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021.
49. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
50. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
51. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
52. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-10163.
53. Barnett SC, Robertson L, Graham D, Allan D, Rampling R. Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells transformed with c-myc and H-ras form high-grade glioma after stereotactic injection into the rat brain. Carcinogenesis 1998; 19: 1529-1537.
54. Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003; 100 (Suppl 1): 11842-11849.
55. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
56. Jones PA, Bayhn SB. The epigenomics of cancer. Cell 2007; 128 683-692.
57. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 2003; 3: 695-701.
58. Michor F, Iwasa Y, Vogelstein B, Lengauer C, Nowak MA. Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol 2005; 15 43-49.
59. Yuen KW, Warren CD, Chen O, Kwok T, Hieter P, Spencer FA. Systematic genome instability screens in yeast and their potential relevance to cancer. Proc Natl Acad Sci USA 2007; 104: 3925-3930.
60. Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: A model for epigenetic tumorigenesis. Gut 2007; 56: 140-148.
61. Luebeck EG, Moolgavkar SH. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci USA 2002; 99: 15095-15100.
62. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003; 21: 1174-1179.
63. Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR, Shastry P. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastorna. Stem Cells 2007; 25: 1478-1489.
64. Melo JV, Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007, 7: 441-453.
65. Sawyers C. Targeted cancer therapy. Nature 2004; 432: 294-297.
66. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657-667.
67. Tsukamoto AS, Reading C, Carella A, Frassoni E, Gorin C, LaPorte J et al. Biological characterization of stem cell present in mobilized peripheral blood of CML patients. Bone Marrow Transplant 1994; 14: S25-S32.
68. Jazwiec: B, Mahon FX, Pigneux A, Pigeonnier V, Reiffers J. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells. Exp Hematol 1995; 23: 1509-1514.
69. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 1996; 87: 1539-1548.
70. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al. Effects of a selective inhibitor of the AN tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996; 2: 561-566.
71. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344 1031-1037.
72. Graham SM, Jorgensen HG, Allan E, Pearson C, Aldorn MJ, Richmond L et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to ST1571 in vitro. Blood 2002; 99: 319-325.
73. Cortes J, O'Brien S, Kantarjian H. Discontinuation of imatinib therapy after achieving a moleculqr response. Blood 2004; 104: 2204-2205.
74. Cortes J, Jabbour E, Kantarjian H, Yin CC, Shan J, O'Brien S et al. Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors. Blood 2007 (prepublished online September 4).
75. Cortes J, O'Dwyer ME. Clonal evolution in chronic myelogenous leukemia. Hematol Oncol Clin North Am 2004; 18: 671-684.
76. Vineis P, Berwick M. The population dynamics of cancer: A Darwinian perspective. Int J Epidemiol 2006; 35: 1151-1159.